| 論文 |
papers |
-
Synthesis and evaluation of in Vivo anti-hypothermic effect of the N- And C-terminus modified thyrotropin-releasing hormone mimetic: [(4S,5S)-(5-methyl-2-oxooxazolidine-4-yl)-carbonyl]-[3-(thiazol-4-yl)-L-alanyl]-L-prolinamide Naotake Kobayashi,Norihito Sato,Katsuji Sugita,Tsuyoshi Kihara,Katsumi Koike,Tamio Sugawara,Yukio Tada,Takayoshi Yoshikawa Chemical and Pharmaceutical Bulletin 69巻4号314頁-324頁 2021年04月
-
Pharmacologic effects of naldemedine, a peripherally acting μ-opioid receptor antagonist, in in vitro and in vivo models of opioid-induced constipation. Kanemasa T,Koike K,Arai T,Ono H,Horita N,Chiba H,Nakamura A,Morioka Y,Kihara T,Hasegawa M Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 31巻5号e13563頁- 2019年05月
-
Correction to: Discovery of the Orally Effective Thyrotropin-Releasing Hormone Mimetic: 1-{ N-[(4 S,5 S)-(5-Methyl-2-oxooxazolidine-4-yl)carbonyl]-3-(thiazol-4-yl)- l -alanyl}-(2 R)-2-methylpyrrolidine Trihydrate (Rovatirelin Hydrate) (ACS Omega (2018) 3:10 (13647-13666) DOI: 10.1021/acsomega.8b01481) Naotake Kobayashi,Norihito Sato,Yuko Fujimura,Tsuyoshi Kihara,Katsuji Sugita,Kouji Takahashi,Katsumi Koike,Tamio Sugawara,Yukio Tada,Hiroshi Nakai,Takayoshi Yoshikawa ACS Omega 4巻4号6977頁-6978頁 2019年04月17日
-
Discovery of the Orally Effective Thyrotropin-Releasing Hormone Mimetic: 1-{ N-[(4 S,5 S)-(5-Methyl-2-oxooxazolidine-4-yl)carbonyl]-3-(thiazol-4-yl)- l -alanyl}-(2 R)-2-methylpyrrolidine Trihydrate (Rovatirelin Hydrate) Naotake Kobayashi,Norihito Sato,Yuko Fujimura,Tsuyoshi Kihara,Katsuji Sugita,Kouji Takahashi,Katsumi Koike,Tamio Sugawara,Yukio Tada,Hiroshi Nakai,Takayoshi Yoshikawa ACS Omega 3巻10号13647頁-13666頁 2018年10月19日
-
Distinct relations among plasma concentrations required for different pharmacological effects in oxycodone, morphine, and fentanyl Atsushi Nakamura,Minoru Hasegawa,Hisanori Ito,Kazuhisa Minami,Katsumi Koike,Naoko Habu-Tomita,Kenkichi Nanba,Kayo Hamaguchi,Eriko Noshi,Hiroshi Hashimoto,Ikuko Nishino,Yoshito Okabayashi,Kiyotaka Koyabu,Tsuyoshi Kihara,Yuka Iwamoto,Yuji Inoue,Minoru Narita,Tsutomu Suzuki,Akira Kato Journal of Pain and Palliative Care Pharmacotherapy 25巻4号318頁-334頁 2011年11月11日
-
Morphine, oxycodone, and fentanyl exhibit different analgesic profiles in mouse pain models Kazuhisa Minami,Minoru Hasegawa,Hisanori Ito,Atsushi Nakamura,Takako Tomii,Mitsunobu Matsumoto,Satoshi Orita,Syuichi Matsushima,Takako Miyoshi,Koichi Masuno,Mikinori Torii,Katsumi Koike,Shinji Shimada,Toshiyuki Kanemasa,Tsuyoshi Kihara,Minoru Narita,Tsutomu Suzuki,Akira Kato Journal of Pharmacological Sciences 111巻1号60頁-72頁 2009年09月
-
Oxycodone-induced analgesic effects in a bone cancer pain model in mice Akira Kato,Kazuhisa Minami,Hisanori Ito,Takako Tomii,Mitsunobu Matsumoto,Satoshi Orita,Tsuyoshi Kihara,Minoru Narita,Tsutomu Suzuki Oncology 74巻SUPPL.1号55頁-60頁 2008年08月
-
野生型マウスにおけるBACE1阻害は内因性Aベータを減少させAPPプロセシングを変化させる NISHITOMI Kouhei,SAKAGUCHI Gaku,HORIKOSHI Yuko,GRAY Audrey J.,MAEDA Masahiro,HIRATA-FUKAE Chiho,BECKER Amanda G.,HOSONO Motoko,SAKAGUCHI Isako,MINAMI S. Sakura,NAKAJIMA Yoshihiro,LI Hui-Fang,TAKEYAMA Chie,KIHARA Tsuyoshi,OTA Akinobu,WONG Philip C.,AISEN Paul S.,KATO Akira,KINOSHITA Noriaki,MATSUOKA Yasuji Journal of Neurochemistry 99巻6号1555頁-1563頁 2006年12月
-
ω-Agatoxin IVA-sensitive Ca2+ channel blocker, α-eudesmol, protects against brain injury after focal ischemia in rats Kenji Asakura,Yoshiyuki Matsuo,Takeo Oshima,Tsuyoshi Kihara,Kazuyuki Minagawa,Yoshitaka Araki,Kiyomi Kagawa,Toshiyuki Kanemasa,Mitsuyoshi Ninomiya European Journal of Pharmacology 394巻1号57頁-65頁 2000年04月07日
-
Change in ascorbate radical production in an irradiated experimental tumor with increased tumor size Hiroyoshi Isoda,Kiyoshi Akagi,Takashi Murata,Yoshizumi Aoki,Shigeki Ikeda,Yoshimasa Tanaka,Takeshi Kihara,Masato Ikeda Cancer Research 56巻24号5741頁-5744頁 1996年12月15日
-
Synthesis and evaluation of in Vivo anti-hypothermic effect of the N- And C-terminus modified thyrotropin-releasing hormone mimetic: [(4S,5S)-(5-methyl-2-oxooxazolidine-4-yl)-carbonyl]-[3-(thiazol-4-yl)-L-alanyl]-L-prolinamide Naotake Kobayashi,Norihito Sato,Katsuji Sugita,Tsuyoshi Kihara,Katsumi Koike,Tamio Sugawara,Yukio Tada,Takayoshi Yoshikawa Chemical and Pharmaceutical Bulletin 69.4.314-324 2021/04
-
Pharmacologic effects of naldemedine, a peripherally acting μ-opioid receptor antagonist, in in vitro and in vivo models of opioid-induced constipation Toshiyuki Kanemasa,Katsumi Koike,Tohko Arai,Hiroko Ono,Narumi Horita,Hiroki Chiba,Atsushi Nakamura,Yasuhide Morioka,Tsuyoshi Kihara,Minoru Hasegawa Neurogastroenterology and Motility 31.5.e13563- 2019/05
-
Correction to: Discovery of the Orally Effective Thyrotropin-Releasing Hormone Mimetic: 1-{ N-[(4 S,5 S)-(5-Methyl-2-oxooxazolidine-4-yl)carbonyl]-3-(thiazol-4-yl)- l -alanyl}-(2 R)-2-methylpyrrolidine Trihydrate (Rovatirelin Hydrate) (ACS Omega (2018) 3:10 (13647-13666) DOI: 10.1021/acsomega.8b01481) Naotake Kobayashi,Norihito Sato,Yuko Fujimura,Tsuyoshi Kihara,Katsuji Sugita,Kouji Takahashi,Katsumi Koike,Tamio Sugawara,Yukio Tada,Hiroshi Nakai,Takayoshi Yoshikawa ACS Omega 4.4.6977-6978 2019/04/17
-
Discovery of the Orally Effective Thyrotropin-Releasing Hormone Mimetic: 1-{ N-[(4 S,5 S)-(5-Methyl-2-oxooxazolidine-4-yl)carbonyl]-3-(thiazol-4-yl)- l -alanyl}-(2 R)-2-methylpyrrolidine Trihydrate (Rovatirelin Hydrate) Naotake Kobayashi,Norihito Sato,Yuko Fujimura,Tsuyoshi Kihara,Katsuji Sugita,Kouji Takahashi,Katsumi Koike,Tamio Sugawara,Yukio Tada,Hiroshi Nakai,Takayoshi Yoshikawa ACS Omega 3.10.13647-13666 2018/10/19
-
Distinct relations among plasma concentrations required for different pharmacological effects in oxycodone, morphine, and fentanyl Atsushi Nakamura,Minoru Hasegawa,Hisanori Ito,Kazuhisa Minami,Katsumi Koike,Naoko Habu-Tomita,Kenkichi Nanba,Kayo Hamaguchi,Eriko Noshi,Hiroshi Hashimoto,Ikuko Nishino,Yoshito Okabayashi,Kiyotaka Koyabu,Tsuyoshi Kihara,Yuka Iwamoto,Yuji Inoue,Minoru Narita,Tsutomu Suzuki,Akira Kato Journal of Pain and Palliative Care Pharmacotherapy 25.4.318-334 2011/11/11
-
Morphine, oxycodone, and fentanyl exhibit different analgesic profiles in mouse pain models Kazuhisa Minami,Minoru Hasegawa,Hisanori Ito,Atsushi Nakamura,Takako Tomii,Mitsunobu Matsumoto,Satoshi Orita,Syuichi Matsushima,Takako Miyoshi,Koichi Masuno,Mikinori Torii,Katsumi Koike,Shinji Shimada,Toshiyuki Kanemasa,Tsuyoshi Kihara,Minoru Narita,Tsutomu Suzuki,Akira Kato Journal of Pharmacological Sciences 111.1.60-72 2009/09
-
Oxycodone-induced analgesic effects in a bone cancer pain model in mice Akira Kato,Kazuhisa Minami,Hisanori Ito,Takako Tomii,Mitsunobu Matsumoto,Satoshi Orita,Tsuyoshi Kihara,Minoru Narita,Tsutomu Suzuki Oncology 74.SUPPL.1.55-60 2008/08
-
BACE1 inhibition reduces endogenous Abeta and alters APP processing in wild-type mice2 Kouhei Nishitomi,Gaku Sakaguchi,Yuko Horikoshi,Audrey J. Gray,Masahiro Maeda,Chiho Hirata-Fukae,Amanda G. Becker,Motoko Hosono,Isako Sakaguchi,S. Sakura Minami,Yoshihiro Nakajima,Hui Fang Li,Chie Takeyama,Tsuyoshi Kihara,Akinobu Ota,Philip C. Wong,Paul S. Aisen,Akira Kato,Noriaki Kinoshita,Yasuji Matsuoka Journal of Neurochemistry 99.6.1555-1563 2006/12
-
ω-Agatoxin IVA-sensitive Ca2+ channel blocker, α-eudesmol, protects against brain injury after focal ischemia in rats Kenji Asakura,Yoshiyuki Matsuo,Takeo Oshima,Tsuyoshi Kihara,Kazuyuki Minagawa,Yoshitaka Araki,Kiyomi Kagawa,Toshiyuki Kanemasa,Mitsuyoshi Ninomiya European Journal of Pharmacology 394.1.57-65 2000/04/07
-
Change in ascorbate radical production in an irradiated experimental tumor with increased tumor size Hiroyoshi Isoda,Kiyoshi Akagi,Takashi Murata,Yoshizumi Aoki,Shigeki Ikeda,Yoshimasa Tanaka,Takeshi Kihara,Masato Ikeda Cancer Research 56.24.5741-5744 1996/12/15
|